Correction: Corrigendum: Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation
Autor: | Tien-Jyun Chang, Hsing-Chi Tseng, Meng-Wei Liu, Yi-Cheng Chang, Meng-Lun Hsieh, Lee-Ming Chuang |
---|---|
Rok vydání: | 2016 |
Předmět: |
Multidisciplinary
Cell Survival digestive oral and skin physiology Apoptosis AMP-Activated Protein Kinases Pyruvaldehyde Corrigenda Cyclic AMP-Dependent Protein Kinases Article Metformin Mitochondria Rats Phosphatidylinositol 3-Kinases Glucagon-Like Peptide 1 Cell Line Tumor Insulin-Secreting Cells Animals Hypoglycemic Agents Signal Transduction |
Zdroj: | Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/srep26917 |
Popis: | Accumulation of methylglyoxal (MG) contributes to glucotoxicity and mediates beta cell apoptosis. The molecular mechanism by which GLP-1 protects MG-induced beta cell apoptosis remains unclear. Metformin is a first-line drug for treating type 2 diabetes associated with AMPK activation. However, whether metformin prevents MG-induced beta cell apoptosis is controversial. Here, we explored the signaling pathway involved in the anti-apoptotic effect of GLP-1, and investigated whether metformin had an anti-apoptotic effect on beta cells. MG treatment induced apoptosis of beta cells, impaired mitochondrial function, and prolonged activation of AMP-dependent protein kinase (AMPK). The MG-induced pro-apoptotic effects were abolished by an AMPK inhibitor. Pretreatment of GLP-1 reversed MG-induced apoptosis, and mitochondrial dysfunction, and suppressed prolonged AMPK activation. Pretreatment of GLP-1 reversed AMPK activator 5-aminoimidazole-4-carboxamide riboside (AICAR)-induced apoptosis, and suppressed prolonged AMPK activation. However, metformin neither leads to beta cell apoptosis nor ameliorates MG-induced beta cell apoptosis. In parallel, GLP-1 also prevents MG-induced beta cell apoptosis through PKA and PI3K-dependent pathway. In conclusion, these data indicates GLP-1 but not metformin protects MG-induced beta cell apoptosis through improving mitochondrial function, and alleviating the prolonged AMPK activation. Whether adding GLP-1 to metformin provides better beta cell survival and delays disease progression remains to be validated. |
Databáze: | OpenAIRE |
Externí odkaz: |